Zyden Gentec has incorporated its 100% wholly owned subsidiary (WOS) in Hong Kong. The board at its meeting held on November 09, 2012 has transacted and took the note of the same.
Zyden Gentec’s principal activity is to manufacture pharmaceutical products and to provide consultancy services. The company operates in two segments namely Manufacturing & Allied Activities and Financial, Investment & Allied Activities. The products of the company include specialized chemicals, bulk drugs, compounds and intermediates.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1845.00 |
| Dr. Reddys Lab | 1281.55 |
| Cipla | 1339.50 |
| Zydus Lifesciences | 932.80 |
| Lupin | 2282.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: